Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (31-40 of 283) with videos related to

Pageof 29
Sort By:
Frontiers in Oncology|January 22, 2026
Vaping, smoking and risk of early onset lung cancerMarisa A Bittoni, David P Carbone, Randall E Harris
Seminars in Oncology|March 15, 2002
Genetic and immunologic therapies for lung cancerStephen G Swisher, Jack A Roth, David P Carbone
Cancer Research|August 10, 2007
Advances and challenges in aerodigestive epithelial cancer: meeting summary and research opportunitiesJennifer R Grandis, David P Carbone, Anil K Rustgi
Critical Reviews in Oncology/Hematology|October 4, 2006
Genomics and proteomics: emerging technologies in clinical cancer researchChristine H Chung, Shawn Levy, Pierre Chaurand, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Long-term smoking mediated down-regulation of Smad3 induces resistance to carboplatin in non-small cell lung cancerDebangshu Samanta, Jacob Kaufman, David P Carbone, et al.
Personalized Medicine|May 23, 2018
Highlights from the latest articles in lung cancer personalized medicineHiram Rivas-Perez, David P Carbone, S Patrick Nana-Sinkam
Cancer Discovery|June 3, 2021
Genetic Ancestry Affects Somatic Alterations in Lung CancersLuiz H Araujo, Vladmir C Cordeiro de Lima, David P Carbone
Clinical Lung Cancer|November 5, 2003
Molecular fingerprinting in human lung cancerKiyoshi Yanagisawa, Baogang J Xu, David P Carbone, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 2023
Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after progression on standard-of-care therapy in the United StatesHozefa A Divan, Marisa A Bittoni, Ashok Krishna, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 7, 2018
Safety of dose-reduced pemetrexed in patients with renal insufficiencyJordan Hill, Craig Vargo, Michael Smith, et al.
Pageof 29

Showing results (31-40 of 283) with videos related to

Sort By:
Pageof 29
Frontiers in Oncology|January 22, 2026
Vaping, smoking and risk of early onset lung cancerMarisa A Bittoni, David P Carbone, Randall E Harris
Seminars in Oncology|March 15, 2002
Genetic and immunologic therapies for lung cancerStephen G Swisher, Jack A Roth, David P Carbone
Cancer Research|August 10, 2007
Advances and challenges in aerodigestive epithelial cancer: meeting summary and research opportunitiesJennifer R Grandis, David P Carbone, Anil K Rustgi
Critical Reviews in Oncology/Hematology|October 4, 2006
Genomics and proteomics: emerging technologies in clinical cancer researchChristine H Chung, Shawn Levy, Pierre Chaurand, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Long-term smoking mediated down-regulation of Smad3 induces resistance to carboplatin in non-small cell lung cancerDebangshu Samanta, Jacob Kaufman, David P Carbone, et al.
Personalized Medicine|May 23, 2018
Highlights from the latest articles in lung cancer personalized medicineHiram Rivas-Perez, David P Carbone, S Patrick Nana-Sinkam
Cancer Discovery|June 3, 2021
Genetic Ancestry Affects Somatic Alterations in Lung CancersLuiz H Araujo, Vladmir C Cordeiro de Lima, David P Carbone
Clinical Lung Cancer|November 5, 2003
Molecular fingerprinting in human lung cancerKiyoshi Yanagisawa, Baogang J Xu, David P Carbone, et al.
Lung Cancer (Amsterdam, Netherlands)|April 1, 2023
Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after progression on standard-of-care therapy in the United StatesHozefa A Divan, Marisa A Bittoni, Ashok Krishna, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 7, 2018
Safety of dose-reduced pemetrexed in patients with renal insufficiencyJordan Hill, Craig Vargo, Michael Smith, et al.
Pageof 29